Health and Life Sciences — The Biggest Opportunity for Australian SMEs in Asia-Pacific

Exploding Health Demand in Southeast Asia

Southeast Asia’s health market is experiencing exponential growth driven by three main factors: rising incomes, an aging population, and growing health awareness. For Australian SMEs in life sciences and healthcare, this is an opportunity that should not be missed.

Vietnam: A Market Dependent on Imports

Vietnam imports more than 90% of its medical equipment. The country also imports 100% of plasma-derived medicines, including immunoglobulins, albumin, and hyperimmune products. This dependence creates stable and sustainable demand for Australian exporters offering high-quality products.

The Vietnamese government is also encouraging greater private sector involvement in healthcare, which in turn increases demand for modern technologies and services.

Malaysia: Medical Tourism Hub with High-End Product Demand

Unlike Vietnam, Malaysia has a well-established manufacturing base. However, the country continues to seek specialized and high-end products not produced locally. Malaysia’s rapidly growing private healthcare sector, combined with its role as a medical tourism hub, creates strong demand for advanced medical services, devices, and pharmaceuticals.

Trade Agreement Framework Supporting Market Access

Trade agreements such as the Regional Comprehensive Economic Partnership (RCEP) and the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), together with ongoing ASEAN regulatory harmonization, are further improving market access and positioning Malaysia and Vietnam as gateways to Southeast Asia.

Real Partnership: Austrade and Long Chau in Vietnam

In September 2026, Austrade successfully connected eight leading Australian health brands with Long Chau, Vietnam’s largest pharmacy chain. The meeting not only strengthened bilateral cooperation in the health sector but also opened new prospects for expanding Australian brands in the Vietnamese market.

Aegros: Plasma Technology Breakthrough in Vietnam

Aegros, an Australian plasma technology company, received a visit from a Vietnamese Ministry of Health delegation to its Macquarie Park facility in July 2026. This was the first foreign government visit to inspect the Haemafrac® technology and their new plant. More information is available at https://www.aegros.com.

The visit marked international recognition of Australia’s capabilities in plasma technology and opened the door for deeper cooperation with Vietnam in health.

Strategies for Entering the Asia-Pacific Health Market

For Australian SMEs in the health sector, several key steps should be considered. First, focus on specific segments where Australia has a clear competitive advantage, such as precision medical devices, plasma products, or digital health solutions. Second, leverage programs such as the Going Global Export Program, which offers direct market missions to Vietnam and Malaysia.

Third, build partnerships with local distributors. Fourth, understand the regulatory and certification processes in each country, because health product registration requirements vary widely. With a targeted approach and the use of available government resources, Australian SMEs can capture significant market share in a region projected to become the world’s fourth-largest economy by 2040.